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ABSTRACT 
Tuberculosis of the central nervous system (CNS TB) is the severest form of tuberculosis. It 
is classified as extra-pulmonary tuberculosis due to dissemination of Mycobacterium 
tuberculosis (Mtb) bacilli from the lung to the brain. It affects mostly children and immune 
suppressed individuals and high incidents of death occur as a result of missed diagnosis and 
delayed treatment. Therefore, the is a need for improved therapeutic strategy and a better 
understanding of the CNS immunity; investigate cells targeted for infection, their respective 
response to infection and interaction with different cell types to the overall protection of the 
CNS - as accumulating evidence indicates a dynamic neuronal lymphocyte interplay that 
defines outcomes of diseases. A novel observation was previously made, that neurons are 
infected by Mtb during in vitro and in vivo infection. The aim of this study was to further 
characterize neural responses induced by mycobacteria using hippocampal primary neuron 
cultures, infected with H37RV and BCG. Secondly, this study investigated the importance 
of interaction between neurons and immune cells in immunity against mycobacterial 
challenge using an optimised neuron T cell co-culture model. Investigation included 
identifying the production levels of neuronal cell surface markers and cytokines induced by 
Mtb. In flow cytometry and ELISA analyses, infection exhibited a robust inflammatory 
response with increased neuronal production of cytokines such as IL1β, IL6, TNF and 
regulatory cytokine IL10 in vitro and in vivo. Neuronal MHC class I expression was 
upregulated by infection, suggesting possible antigen dependent interactions between neuron 
and CD8+ T cells. In co-cultures, neurons induced expression of Tbet, RorγT and Gata3 T 
cell transcription factors through direct contact with T cells. These data highlighted the 
likelihood of neurons activating T cells upon mycobacterial stimulations. It may potentially 
be utilised to broaden the understanding of CNS immunity under pathological conditions 
and possibly lead to identification of novel immunomodulatory targets that could be 
exploited for new rapid sensitive diagnostics and early opportune intervention against CNS 
TB – reducing morbidity and mortality associated with the disease. 
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1. INTRODUCTION 
1.1. The Epidemiology of Tuberculosis 
Tuberculosis (TB) remains one of the most life threatening communicable diseases in the 
world, claiming millions of lives annually. In 2015, 10.4 million people estimated to have 
fallen ill with TB and 1.4 million cases succumbed to the disease (WHO, 2016). Globally, 
11% of new TB cases were co-infected with HIV. TB now outranks HIV as the infectious 
leading cause of death worldwide (WHO, 2016). This is despite the disease being largely 
curable and the progressive improvements in access to TB treatment in the last decade.  
1.2. The Pathogenesis of Tuberculosis 
Tuberculosis is caused by an intracellular bacterium, Mycobacterium tuberculosis (Mtb), and 
is transmitted when the organism is aerosolised by the cough of an infected patient and 
inhaled into the alveoli of a new host (Alland et al., 1994). The introduction of Mtb bacilli 
into the lungs can cause respiratory infection characterised pathologically by necrotic 
granulomas, termed pulmonary TB which can later disseminate to other organs resulting in 
extra-pulmonary TB (Rieder et al., 1990, Solovic et al., 2013). In the lung, after aerosol 
inhalation, bacteria are taken up by resident macrophages and a series of complex 
interactions with the host take place, more macrophages are recruited to the site, specific T 
cells begin to accumulate, and a granuloma is formed (Ramakrishnan, 2012). The statistics 
show that one-third of the world's population is infected with Mtb but only 12% of these 
individuals actually develop the disease (Vynnycky and Fine, 1997) and a successful arrest of 
the infection results asymptomatic and non-transmissible latent infection (Smith, 2003). 
Before the infection is contained in granulomas, bacilli are filtered into draining lymph 
nodes, where there is a low-level bacteraemia in which Mtb disseminates to distant sites in 
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the body resulting in extra-pulmonary TB (Solovic et al., 2013).  Of all TB cases, ~ 80% are 
pulmonary TB with 15% of the burden due to extra-pulmonary TB. Extra-pulmonary TB is a 
disease outside the lungs, can be found in nearly every organ system including the central 
nervous system (CNS) (Solovic et al., 2013).  
1.3.  Central Nervous System Tuberculosis (CNS TB) 
Mtb is the most common cause of CNS infection (John et al., 2015) with the most global 
burden in sub-Saharan Africa and Asia (Berman et al., 1992, Deeny et al., 1985, van Well et 
al., 2009). Central nervous system tuberculosis (CNS TB) affects 1-5% of all active TB cases 
of tuberculosis and it is associated with high morbidity and mortality (Thwaites et al., 2013, 
Garg, 1999). It mostly affects children and immune suppressed individuals (Okike et al., 
2014, Vinnard and Macgregor, 2009). It is the severest form of TB caused by haematogenous 
dissemination of Mtb to the brain followed by the development of Rich foci (small 
tuberculous lesions) in the brain, spinal cord or meninges and remains dormant. Rupture or 
growth of the lesions into the subarachnoid space leads to disease development (Isabel and 
Rogelio, 2014, Donald et al., 2005) (Figure 1-1). CNS tuberculosis may manifest itself as 
tubercular encephalitis, intracranial tuberculomas, or a tuberculous brain abscess and most 
commonly as tuberculous meningitis (TBM) (Be et al., 2009). After the release of tubercle 
bacilli from granulomatous lesions into the subarachnoid space, a dense gelatinous exudate 
forms - containing variety of cells including lymphocytes. Such immune host factors 
determine whether the infection is contained and if the dissemination of the bacilli leads to 
clinical disease, in a case of excessive inflammation (Isabel and Rogelio, 2014). The host 
immune response contributes to defence against invading pathogens and subsequent damage 
to the nervous system (Bailey et al., 2006).  
 3 
 
Improved understanding of the pathogenesis of CNS TB, type and role of specific cells 
involved, the realization of the cause of chronic neurological, cognitive and behavioural 
disease may bring about efficient prevention of infection, limit the persistence of neuronal 
dysfunction and enhance neuroprotection. 
        
Figure 1-1: Schematic illustration of the pathogenesis of tuberculous meningitis (TBM) 
postulation of the formation of Rich foci. (a) Aerosol transmission of Mtb (b) Phagocytosis 
of Mtb by alveolar macrophages inside alveoli. (c) Granuloma formation in the lung (d) Mtb 
escapes from the granuloma (e) Mtb bacilli are filtered into draining lymph nodes (f) After 
spreading through the blood circulation, Mtb can enter the CNS through the blood brain 
barrier (BBB). (g) Bacilli seed to the meninges or the brain parenchyma, forming Rich foci.  
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1.3.1. Different cell types targeted for infection in the CNS including neurons 
Mtb encodes specific proteins that actively facilitate entry into cells in order to establish 
infection. Several studies have reported on different cell types targeted by Mtb for invasion 
(Wolf et al., 2007, Teitelbaum et al., 1999, Munoz et al., 2009, Garcia-Perez et al., 2003). 
Amongst these, macrophages are well described as preferred host cells in the lung (Stanley 
and Cox, 2013, Pieters, 2008, Cambier et al., 2014). Other cells such as dendritic cells are 
also infected by Mtb at a higher rate than previously thought (Wolf et al., 2007).  
In the CNS, microglial cells are regarded as the resident macrophages and principal target for 
Mtb (Curto et al., 2004, Rock et al., 2005, Rock et al., 2004b). This was demonstrated in a 
culture of mixed glia where Mtb showed selective association with microglia than astrocytes 
(Rock et al., 2008, Rock et al., 2005). Nonetheless, neurons, microglia and astrocytes are all 
potential hosts for pathogen in the CNS (Rock et al., 2004a, Rambukkana et al., 2002). An 
early study has found cultured rat dorsal root ganglion neurons could be invaded by 
intracellular bacterium Listeria monocytogenes (L. monocytogenes) efficiently by 
internalization and also via cell-to-cell spread from infected phagocytes (Dramsi et al., 1998). 
Later, neurons were shown to control L. monocytogenes infection in an interferon gamma 
(IFN-γ) dependent manner (Jin et al., 2004, Jin et al., 2001). Mycobacterium leprae (M. 
leprae) is another intracellular bacterium that has been shown to be associated with neurons. 
The study indicated that M. leprae invasion is not the cause of demyelination but the 
bacterial attachment alone is sufficient to induce nerve pathology via contact dependent 
mechanisms (Rambukkana et al., 2002). The recent observation of neurons as Mtb hosts is a 
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novel discovery demonstrated by in vitro and in vivo infection of neurons by Mtb (Randall et 
al., 2014).  
1.4. Immune response in CNS homeostasis and disease 
CNS immunity is comprised of innate and adaptive immunity operated by CNS-resident cells 
and infiltrating immune cells. Almost all pathological changes within the CNS elicit a 
prominent inflammatory reaction (Lucas et al., 2006, Klein et al., 2017). CNS inflammation 
in response to pathogen infection is a highly regulated process to limit potential pathological 
damage. The nature of inflammation in the CNS is often not well defined due to the notion of 
the CNS as an immune privileged site. However, there is new understanding that CNS is not 
as immune privileged as previously described (Louveau et al., 2015, Gadani et al., 2015). T 
cells can gain entry into the CNS under physiological conditions to constantly survey for 
maintenance of the CNS homeostasis, for resolution of infections, degeneration and tissue 
damage (Engelhardt and Ransohoff, 2005, Ransohoff and Engelhardt, 2012). Not only can 
immune cells cross the blood-brain-barrier (BBB), the resident CNS cells (neurons, 
microglia) play a huge role in regulating inflammatory immune responses (Sternberg, 2006, 
Tian et al., 2009, Tracey, 2002). These resident cells express specific adhesion molecules to 
maintain the CNS homeostasis and to prevent excessive inflammation.  
When microglia and astrocytes are infected with mycobacteria, high levels of 
proinflammatory cytokines are produced (Rock et al., 2005).The release of cytokines such as 
tumour necrosis factor (TNF), interleukin 1 (IL1), interferons etc. and production of 
chemokines recruit immune cells to the site of infection and form part of host defence 
mechanisms in the subarachnoid space, increasing the efficiency to eliminate pathogens. 
Production of TNF alpha (TNF-α) during CNS inflammation plays a key role in 
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inflammatory response.  Moreover, it has been shown that TNF-α is essential for host 
protective immunity against CNS TB (Francisco et al., 2015a). High interleukin 4 (IL4) 
expression was also found in H37Rv infected brain (Isabel and Rogelio, 2014) and molecules 
such as transforming growth factor beta (TGF-β), interleukin 10 (IL10) and IL4 in 
neuroinflammation downregulate proinflammatory molecules and dampen immune responses 
(Hendrix and Nitsch, 2007) in an immune regulatory manner, displaying their 
neuroprotective activities. CNS injury is associated with a T helper 2 (Th2) skew (Walsh et 
al., 2015, Gadani et al., 2015) which in the context of CNS mycobacterial infection may be 
important in down regulating T helper 1 (Th1) responses and facilitating neuronal survival. 
The role of T cells in CNS viral infections is well established, regulatory IL10 down regulate 
T helper 17 (Th17) driven inflammation (Kulcsar et al., 2014, Martinez et al., 2012). IFN-γ 
producing CD8+ T cells are important in restraining CNS viral infection and preventing re-
infection (Verjans et al., 2007, Khanna et al., 2003). CD4+ and CD8+ T cells act together in 
addition to TNF-α and IFN-γ and they use perforin and Fas ligand to potentiate cytotoxicity 
of viral infected cells (Stohlman et al., 2008, Tishon et al., 2006). In other neuroinflammatory 
diseases such as Multiple Sclerosis (MS), insufficient regulatory responses by T regulatory 
cells (Tregs) contributes to CNS pathology due to their inability to reduce inflammatory T 
cell (IFN-γ producing Th1 and IL17 producing Th17 cells) responses (Liblau et al., 2013, 
Luchtman et al., 2014). The amount of FoxP3 expression by Tregs is directly proportional to 
their capacity to suppress inflammatory T cells (Venken et al., 2008, Liu et al., 2015). The 
balance between Tregs cells and inflammatory T cells is important for CNS homeostasis and 
preventing neuroinflammation.                                                                                                                            
1.4.1. Neuron T cell interaction 
 7 
 
Several studies have identified various neuronal pathways that regulate immunity and 
inflammation. For a while the role of neurons in regulation of CNS inflammation was 
addressed mainly through their interaction with CNS resident antigen presenting cells. 
Neurons were not viewed as players in control and modulation of immune responses. 
However, recent research applying immunological methods to neurological studies have 
highlighted that neurons function as immune regulators through their control on glial cells 
and infiltrated T cells. Neurons have been shown to induce T cell apoptosis (Flugel et al., 
2000) and inhibit immune responses through contact and contact independent mechanisms 
(Tian et al., 2009). In experimental models of MS, neurons can directly alter the phenotype 
and function of CD4 T-cells (Liu et al., 2006).  
The role of neurons in the immunological defence against CNS pathogens has always 
believed to be passive because neurons do not express major histocompatibility complex 
(MHC II). However, neurons can express major histocompatibility complex (MHC I) 
molecules in the CNS (Shatz, 2009, Foster et al., 2002, Chacon and Boulanger, 2013, 
Cebrian et al., 2014). The expression has been shown in response to viral infections 
(Chevalier et al., 2011) and exposure to IFN-γ (Neumann et al., 1995). The expression of 
MHC I and not MHC II on neurons have suggested that antigen dependent responses may be 
confined to neuron - CD8+ T cell interaction (Chevalier et al., 2011). Neuronal MHC I can 
interact with Cis and Ly49 receptors of immune cells (Held and Mariuzza, 2008, Scarpellino 
et al., 2007)  and has also been shown to signal through T cell receptor co-receptor CD3 in 
the brain (Syken and Shatz, 2003). In CNS viral infections neuron CD8+ T cell interaction 
induces cytotoxic mediated killing of infected neurons (Meuth et al., 2009, Medana et al., 
2000, Chevalier et al., 2011, Cebrian et al., 2014). However, mechanism utilized by T 
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lymphocytes to control pathogens varies, and CD8+ mediated killing may include Fas ligand, 
perforin and/or granzymes (Liblau et al., 2013).  Neurons can upregulate surface expression 
of Fas upon infection and this promotes pathogen clearance by inducing death of infected 
cells (Figure 1-2). 
 
Figure 1-2: Schematic illustration of the consequences of antigen-specific CD8 T cell 
interactions with neurons. Reproduced from: (Liblau et al., 2013). T cell receptors (TCRs) 
recognise antigenic peptides associated with MHC class I molecules. Following activation, 
CD8 T cells cytotoxic factors such as perforin and granzymes A and B contained in secretory 
lysosomes called lytic granules CD8 T cells also release cytokines such as interferon (IFN)-γ 
and tumour necrosis factor (TNF)-α which affect the biology of the neurons that express their 
receptors, sensitizing them to apoptosis (Neumann et al., 1997, Mizuno et al., 2008) . Fas 
ligand at the cell surface of the CD8 T cells can engage Fas expressed by neurons and initiate 
an apoptotic cascade (Zohar et al., 2008, Medana et al., 2000, Cebrian et al., 2014).  
 
Neuron T cell interactions are not only confined to CD8+ T cells in CNS inflammation. 
Three major subsets dominate the T cell inflammation profile, namely; CD4+, CD8+ and 
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regulatory CD4+ T cells. Each sub-population has distinct functions within the CNS. All T 
cell subsets are all important under homeostatic physiological conditions and control of 
inflammation. However, regulatory T cells have been shown to contribute more to CNS 
homeostasis and most importantly, counter balancing inflammation in a less regenerative 
CNS setting. T cell responses in the brain have both beneficial and detrimental effects on 
brain function (Gadani et al., 2015). Surface molecules expressed on T cells reflect their 
maturity and activation, thus their phenotype and their probable role in response to 
inflammation.  
The interaction of CD4+ T cells with neurons are less characterized in infection because 
neurons do not express MHC II. Nonetheless, during inflammation Th17 exhibit a 
preferential ability to engage sustained contacts with neurons (Liu et al., 2015, Egen and 
Ouyang, 2010) and Th17 and Th1 can regulate innate immune responses in the CNS and 
enhance bacterial clearance (Holley and Kielian, 2012). Other studies have also described 
interesting MHCII-independent neuron CD4+ T cell interactions where neurons can directly 
alter the phenotype and function of activated CD4 T cells to that of regulatory T cells (Liu et 
al., 2006). Additionally, during CNS injury, neurons release damage-associated molecules 
that induce a neuroprotective CD4+ T cell response that is independent of MHCII/TCR 
interactions (Walsh et al., 2015). Together, these studies point towards a complex 
relationship between neurons and adaptive immune responses within the CNS, with neurons 
now regarded as important players in directing such responses.  There is still lack of 
complete understanding of interaction between the CNS and the immune system, and 
mechanisms associated with the role of T cells in neuroprotection and/or neurodegeneration 
in the CNS. Protective and pathogenic T cell responses occur in response to infection but the 
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pathway by which antigens are able to exit the CNS to prime T cells in the periphery remains 
unknown. With new lymphoid structures discovered in association with the brain and now 
also challenging the pathway of antigen recognition and signal for immune surveillance and 
response, more research is still needed. 
 
1.5. Study Aims 
The role of neurons in the immunological defence against CNS pathogens has always 
believed to be passive because neurons do not express MHC II. However recent studies have 
shown that during viral infection neurons express MHC I and interact with CD8 T cells. 
Another evidence of direct immune-regulatory role of neurons on T cells was observed in the 
studies of experimental autoimmune encephalomyelitis where neurons can directly alter the 
phenotype and function of CD4 T cells. Therefore, the aims of this project are: 
 To characterize neuronal responses induced by mycobacteria. 
 To establish a co-culture model of immune and neural function. 
 To investigate the importance of interaction between neurons and immune cells in 
immunity against mycobacterial challenge. 
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2. METHODS 
2.1. Ethics Statement 
Ethical approval was obtained from the Animal Ethics Committee of the University of Cape 
Town (UCT) – protocol number 015/010. Male and female C57BL/6 mice between 6-8 
weeks old were bred and maintained at UCT animal unit under specific pathogen free (SPF) 
conditions. Mice were housed in filter top cages at the biosafety level 2 facilities at UCT. 
2.2. Primary neuron culture 
2.2.1. Treating plates with poly-l-lysine 
To provide better cell attachment, the day before primary neuron culture preparation, plates 
were coated with 0.01% poly-l-lysine (Sigma, MO, USA) dissolved in dH2O and filtered to 
sterilize. The plate was incubated with 1ml of the poly-l-lysine solution in each well at 4°C 
for 24 hours. Poly-l-lysine solution was removed and the plate was rinsed thrice with sterile 
water. 
2.2.2. Dissection of the hippocampus 
Adult mice were mated with the ratio of three female mice to one male mouse. Pregnant mice 
were monitored for 17 days and then euthanized with 5% Halothane (Safeline 
pharmaceuticals). To uncover the foetuses from pregnant female, incision was made along 
the abdomen of the pregnant female then the uterus was removed. Foetuses were taken out 
still in their placental sacs, and the sacs were opened without hurting the heads. The 
umbilical cord was cut then foetuses were removed from the placental sacs. The foetuses 
were euthanized by decapitation using sharp scissors and heads were collected into 50ml tube 
containing dissection medium - Hank’s balanced salt solution (HBSS) (Lonza, MD, USA) for 
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transportation to the laminar flow. Under the laminar flow, the skull was opened and brains 
were suspended in HBSS (Figure 2-1). Hippocampus was chosen for primary neuron cultures 
as pyramidal neurons, the principal cell type in the hippocampus account for a vast majority 
of total neuronal population and they express key neuronal phenotypic features in culture 
(Kaech and Banker, 2006). Meninges-free hippocampi were dissected under the microscope 
(Figure 2-2) and collected into 15ml tube containing 5ml of HBSS on ice.  
 
Figure 2-1: Illustration of the technique to remove brains from embryonic day 17 (E17) 
mouse foetuses. (a,b) Foetus decapitation and removal of the head using sharp scissors. The 
skin was cut open from the back to the front to expose the skull. (c) Forceps were then used 
to pull the skin from the skull. (d,e) and the skull was also removed, revealing the brain. (f) 
Forceps were gently placed underneath the brain and separated it from underlying tissue. 
(g,h) The brain was gently scooped out and quickly submerged into dissection medium 
(HBSS [Lonza]). Source: (Beaudoin et al., 2012) 
 13 
 
 
Figure 2-2: Illustration of the dissection of the hippocampus from the mice foetal brain. (a) 
The brain was placed with dorsal side up in HBSS. (b) The hindbrain region and the two 
hemispheres were separated by indicated incisions. (c) The hemisphere was placed side down 
and forebrain tissue was removed. (d) The hemisphere was gently held in place to avoid 
damage to the hippocampus. (e) The meningeal tissue was removed with another pair of 
forceps. (f) Hippocampus was dissected out. Source: (Beaudoin et al., 2012) 
2.2.3. Cell dissociation and plating 
The tissue was allowed to settle before the HBSS was removed and 500µl – 1ml of Papain 
digestion buffer (0.1% papain [Sigma, MO, USA], 0.02% BSA [Roche, Mannheim, 
Germany] in neurobasal medium [Gibco, NY, USA]) was added and incubated in a 37°C 
water bath for 10 minutes. The supernatant was carefully removed and to wash residual 
papain, 5ml of Neurobasal medium (Gibco) was added and tube was left to stand at room 
temperature (RT) for tissues to settle before removing the supernatant and this was repeated 
twice. 1ml of Plating neurobasal medium (2% B27 supplement [Gibco, NY, USA], 1% L-
glutamine [Gibco, NY, USA] in neurobasal medium [Gibco]) was added and tissues were 
dissociated by trituration using P1000 pipette. Once homogenous suspension was achieved, 
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10µl aliquot of dissociated cells was taken to determine viable cell density using 
haemocytometer. 10µl of Trypan Blue (0.4% trypan blue solution [Sigma]) was added to 
10µl of cells and viable cells were identified by their light glossy appearance. To calculate 
number of viable cells, average cell count was multiplied by 2 from trypan blue addition, and 
then multiplied by 104. 
Number of cells to be seeded was determined based on the type of plate used (Table 2-1). 
These provided sufficient cell density for neuronal cell development to confluency. Cells 
were added to 48 well plate for neuron T cell cell-to-cell contact experiments, or 24 well 
plate for transwell - contact independent experiments (Table 2-1). Plates were sealed with 
micro-pore tape and incubated at 37°C with 5% carbon dioxide (CO2) until confluency 
(Figure 2-3). Media were partly changed every 3-4 days using plating neurobasal medium 
warmed in 37°C water bath. 
Table 2-1: Seeding densities of primary neuronal cultures 
Culture type Plate type Experiments/ 
Applications 
Well area Number of 
cells to plate 
per well 
Neurobasal 
medium final 
volume/ well 
Primary 
neurons 
48 wells - neuron T 
cell direct 
contact co-
culture 
0.95 cm2 3x105 300ul 
24 wells -transwell 
-ICC 
1.91 cm2 4x105 500ul 
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Figure 2-3: Phase contrast images of hippocampal neuron cultures after 1 day (a) and 13 
days in culture. Source: (Kaech and Banker, 2006). 
2.3. Infection of Primary Neurons 
2.3.1.  Mtb Strain H37RV/ H37Rv-GFP and BCG-GFP Stock Preparation 
H37Rv/ H37Rv-GFP (kindly provided by Joel Ernst, New York University School of 
Medicine, New York, USA) and BCG-GFP were cultured for 21 days in DifcoTM 
Middlebrook 7H9 broth (Becton) containing 0.5% glycerol, 10% oleic acid-albumin-
dextrose-catalase (OADC) (BD Biosciences, MD, USA) and 50μl/ml Kanamycin (Santa 
Cruz, CA, USA) or Hygromycin B (Roche) and incubated at 37°C, 5% CO2. The 
mycobacteria without GFP expression (H37Rv) were cultivated in the absence of antibiotics. 
1ml aliquots were prepared in sterile conditions and stored at -80°C in 2ml screw cap vials 
(Greiner bio-one, Cryo Cellstar). To determine viable Mtb concentrations of the frozen 
stocks, 10-fold serial dilutions were made and plated on DifcoTM Middlebrook 7H10 agar 
(Becton) plates containing 10% OADC, 50 μl/ml Hygromycin B or Kanamycin and 
incubated at 37°C, 5% CO2 for 21 days. The final viable Mtb concentration was calculated 
based on the number of colonies counted.  
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2.3.2. Inoculation of H37Rv and BCG 
BCG and H37Rv stocks were stored at -80°C freezers in biosafety level 2 (BSL2) and 
biosafety level 3 (BSL3) laboratory respectively. Mycobacteria were thawed at RT, 
centrifuged at 10000rpm at 4°C for 10 minutes to remove glycerol. The pellet was 
resuspended in plating neurobasal medium. To reduce clumping, the BCG suspension was 
passed through a 29-gauge needle 30 times. On the other hand, due to the health and safety 
reason, no sharps was allowed in BSL3 laboratory, therefore the H37Rv suspension was 
transferred into tubes containing 2-3 mm glass beads and vortexed vigorously for one minute. 
Primary neurons were infected at multiplicity of infection (MOI) of 30:1. The plate was 
sealed with micro-pore tape and incubated at 37°C, 5% CO2 for 24 hours of which optimal 
infectivity can be achieved as previously shown (Randall et al., 2014). 
2.4. Co-culture with T Lymphocytes 
To obtain naïve T Cells, spleens were collected from naïve 6-8 weeks old C57BL/6 mice into 
10 ml 1X PBS (0.137M NaCl, 2mM KH2PO4, 3mM KCl, 8mM Na2HPO42H2O) on ice. For 
single cell suspension – spleens were pressed through 70-micron sieve using a syringe 
plunger, and cells were collected by centrifugation for 5 minutes at 1200rpm at 4°C. 
Supernatant was discarded, the pellet was resuspended in 1-2ml of Red blood cell lysing 
buffer (0.15M NH4Cl, 1mM KHCO3, 0.1M Na2EDTA) and left to stand for 1-2 minutes at 
RT. Following neutralization and centrifugation, supernatant was discarded. The cells were 
incubated with CD3 antibody (25µl to 106 cells) (Table A-1) for 20 minutes at 4°C then 
washed with FACS buffer. Supernatant was discarded and the pellet was resuspended in 5ml 
of neurobasal medium and filtered through 0.22µm FACS tube filter to remove remaining 
clumps. CD3+ T Cells were sorted using Fluorescent Activated Cell Sorting (FACS) (BD 
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FACSAria) into 15ml falcon tubes containing 2ml neurobasal medium (Figure A-1). Due to 
technical issues of the cell sorter, in BCG experiments, the CD3+CD4+ and CD3+CD8+ T cell 
populations were obtained by manual sort using the Miltenyi Biotec Magnetic Activated Cell 
Sorting (MACS) bead system according to manufacturer guidelines 
https://www.miltenyibiotec.com/~/media/Images/Products/Import/0001900/IM0001983.ashx
?force=1. To determine viable T cell density, 10µl aliquot of sorted cells was taken, added to 
10µl trypan blue and density of cells was determined on a haemocytometer. The T cells were 
added to neuronal cultures at a ratio of 1:1 after 24 hours of neuronal infection. For neuron 
and T cell cell-to-cell contact, T cells were added directly neurons and the effects of this 
contact were evaluated against cultures where neurons and T cells were separated by a 
transwell membrane. To study the effects of infected neuron on T cells in the absence of 
possible contact or communication, neuron conditioned media was added to T cells. The co-
cultures were incubated for 48 hours at 37°C, 5% CO2 as it was previously shown (Randall et 
al., 2014) that neurons induce an immune response after 48 hours Mtb infection.   
2.5. Flow Cytometry (FACS) 
Flow cytometry was used to analyse the expression of cell surface proteins and intracellular 
proteins using florescent labelled monoclonal antibodies. To prepare cells for FACS staining, 
the culture plates were centrifuged to settle floating cells and supernatants were collected for 
ELISA analysis. Adhered cells were lifted using 200µl/well of 1X Trypsin EDTA (10X 
Trypsin EDTA [Gibco] diluted in HBSS [Lonza]) and incubated for 5 minutes at 37°C, 5% 
CO2. To neutralise trypsin reaction, equivalent volume of plating neurobasal medium was 
added. For each co-culture well, the volume was halved for staining both the neuronal 
antibody panel (Table A-2) and T cell antibody panel (Table A-1).  
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2.5.1. FACS extracellular staining 
Lifted Cells were transferred to a 96 well plate and then washed with FACS buffer (0.1% 
BSA, 0.01% NaN3 in 1X PBS, pH 7.4). For staining, 25µl/well (25µl to 106 cells) of Ab 
cocktail for each panel was added and incubated at 4°C for 20 minutes. Cells were then 
washed with FACS buffer, fixed in fixation buffer (2% paraformaldehyde in 1X PBS, 4% 
NaOH in dH2O, pH 7.2) and stored at 4°C before intracellular staining. 
2.5.2. FACS intracellular staining 
2.5.2.1. Neuron Panel 
For intracellular staining of the cells, fixation buffer was removed and 200µl/well FACS 
buffer was added to wash. Then 200µl/well of permeabilization buffer (1% saponin in FACS 
buffer) was added for 30 minutes at 4°C. Centrifuged for 10 minutes, 1200rpm, 4°C and 
discarded supernatant. 25µl/well of intracellular Ab cocktail (Table A-2) was added and 
incubated for 20 minutes then washed with 200µl/well permeabilization buffer. Cells were 
kept in 200µl/well fixation buffer and stored at 4°C until flow cytometry acquisition. 
Analysis of primary neurons was based on gating in figure A-2. 
2.5.2.2. T cell transcription factors panel 
Intracellular staining of T cell transcription factors was performed according to BD 
Biosciences transcription factors (Table A-1) staining protocol 
http://www.bdbiosciences.com/ds/pm/tds/562725.pdf. Stained T cells were stored in 
200µl/well of FACS buffer at 4°C until flow cytometry acquisition. Analysis of T cells was 
based on gating in figure A-3.  
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Acquisition was done on BD LSRFortessa and data analysis of FCS files was done using 
FlowJo version 9.8.5. 
2.6. Enzyme-linked Immunosorbent assay (ELISA) 
ELISA was used to detect and quantify cytokines of interest in Table A-3. Supernatants 
collected after 48 hours of co-culture were analysed by ELISA. The plate was centrifuged for 
5 minutes, 800rpm, 4°C to settle floating cells and supernatants were collected and filtered 
using a 0.22µm filter (Merck Millipore) and lure lock syringe into sterile Eppendorf (UCT 
BSL3 facility requirements) and stored at -80°C. To coat the ELISA plate, capture antibody 
was diluted appropriately (Table A-3) in dilution buffer (1% BSA, 0.02% NaN3 in 1X PBS) 
and maxisorb nunc 96 well plate (Nalge, Nunc International, USA) was coated with 
50µl/well of the anti-cytokine antibody and left overnight at 4°C. Plate was washed 4 times 
with washing buffer (13.4mM KCl, 5.8mM KH2HPO4.2H2O, 700mM NaCl, and 2.03mM 
Tween 20). It was then blocked with 200µl/well blocking buffer (4% BSA, 0.02% NaN3 in 
1X PBS), left at 4°C overnight or incubated at 37◦C for 2 hours and washed 4 times. 
50µl/well recombinant cytokine standards (Table A-3) and samples were added and plates 
were incubated overnight at 4°C or for 2 hours at 37°C. 50µl/well of Biotinylated Secondary 
Ab (Table A-3) was added and incubated for 1 hour at 37◦C. The plate was washed 4 times 
with washing buffer. Streptavidin alkaline phosphatase (BD PharmigenTM) was diluted 
1:1000 in dilution buffer (1% BSA, 0.02% NaN3 in 1X PBS) and 50µl/well was added, 
incubated again for 1 hour at 37°C and washed the plate 4 times. Substrate buffer prepared at 
a dilution of 0.05g 4-nitrophenyl disodium salt-hexahydrate in 50ml substrate buffer (0.02% 
NaN3, 1.04M Di-ethanolamine, 3.9mM MgCl2.6H2O, pH 9.8 with 10M HCL) and 50µl/well 
was added. The reaction was allowed to develop and the plate was read at 405nm (492nm 
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reference wavelength) on an ELISA reader (Molecular Devices, Spectra MaxGemini, USA) 
using Soft Max programme. 
 
2.7. In vivo – intracerebral H37Rv/BCG infection 
Four to five C57BL/6 female mice were inoculated intra-cerebrally in the left cerebral 
hemisphere with 1x105 CFU of H37Rv or BCG-GFP using Hamilton syringe. For H37Rv 
infection experiments, mice were euthanized at 7, 14 and 21 days’ post infection. Brains 
were remove from the skulls and were pressed through 70-micron sieve for single cell 
suspension. To determine the number of viable cells to be stained, 10µl of cells were added 
to 10µl of trypan blue and cell number was determined using a haemocytometer. 
Extracellular and intracellular staining protocols were followed as previously outlined (2.5.1 
& 2.5.2) and the antibodies used for staining are shown in Table A-4. BD LSRFortessa was 
used for acquisition and data analysis was done using FlowJo version 9.8.5. Analysis of 
neurons was based on gating strategy illustrated in Figure A-4. 
2.8. Statistical Analysis 
Statistics were performed with GraphPad Prism 6 statistical software. Statistical methods 
used were Student unpaired t-test (Two-tailed), one-way ANOVA with Bonferroni’s post test 
and 2way ANOVA with Bonferroni’s post test. A	P	 value	of	 less	 	 than	0.05	was	considered	
significant.  
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3. RESULTS 
3.1. Neuronal mycobacterium tuberculosis uptake and response 
3.1.1. Primary neurons internalize Mtb in vitro 
The causative agent of TB, Mycobacterium tuberculosis, preferentially infects macrophages 
in pulmonary infection and microglia in CNS infection. It is now known that Mtb can also 
infect a variety of cells including “non-classical” immune cells such as epithelial cells and 
fibroblasts (Randall et al., 2015). A novel observation was previously reported that neurons 
were infected by Mtb during in vitro and in vivo infection (Randall et al., 2014). To further 
characterize whether the pathogenesis of neuronal infection depends on the virulence of the 
bacteria, primary neuronal cultures were infected with either virulent (H37Rv) or avirulent 
(BCG) strain of mycobacteria.  Primary neurons cultivated from hippocampus of embryonic 
day 17 (E17) C57BL/6 mice (2.3.2) were infected with a recombinant GFP expressing 
H37Rv (Mtb laboratory strain) at multiplicity of infection (MOI) of 30:1 for 24 hours. 
Similarly, primary neurons were also infected with Bacillus Calmette–Guérin expressing 
GFP (BCG-GFP) (2.4.2). Post infection, cultured neurons were stained with β-III-tubulin 
antibody, a neuronal marker and analysed by flow cytometry. β-III-tubulin+ neurons 
containing GFP+ bacilli were detected in both H37Rv-GFP and BCG-GFP infected cultures 
(Figure 3-1). The percentage of neurons infected by H37Rv-GFP was 13% (Figure 3-1 A), 
which falls in the same range as previously reported (Randall et al., 2014). On the other hand, 
the flow cytometry analysis revealed that the percentage of βtubulin+ GFP+ neurons was 5% 
in the BCG-GFP infected cultures (Figure 3-1 B). Although the percentage of BCG-GFP 
infection was lower than the H37Rv-GFP infection, this is the first evidence to suggest direct 
interaction between neurons and BCG. 
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Figure 3-1: Flowcytometry analysis of β-III-tubulin+ GFP+ primary neurons cultures infected 
with (A) H37Rv-GFP and (B) BCG-GFP for 24 hours. Neuron cultures were infected at MOI of 
30:1 and results represent percentage of primary neurons that internalized Mtb bacilli (GFP and 
β-III-tubulin double positive cells). 13% of cells in Mtb infected neuron cultures have detectable 
expression of GFP and a lesser percentage (5%) of cells expressed GFP in BCG-GFP infected 
cultures. Data are mean ± SD. *P < 0.05, **P < 0.01. NI – non-infected 
3.1.2. How do neurons respond to mycobacterial infection?  
Neurons are shown to be activated during Mtb infection (Randall et al., 2014). However, the 
impact of mycobacterial infection on neuronal immune reaction is not clear. To address that, 
primary neurons were grown in culture until confluency (2.3.3) and infected with H37Rv at 
MOI of 30:1 for 24 hours (2.4.2). Infected cultures were compared with non-infected 
cultures. To assess phenotypic changes activated through neuronal interaction with Mtb, the 
expression of surface markers associated with cellular or neuronal response to stimuli were 
examined. Post infection, primary neurons were stained using fluorescent labelled 
monoclonal antibodies for flow cytometry analysis. Interaction of primary neurons with live 
Mtb resulted in cell activation reflected by changes in neuronal surface expression (Figure 3-
2) and cytokine expression (Figure 3-3). Upon infection, the frequency of MHC I expression 
on neurons was found to be significantly higher than the non-infected (Figue 3-2 A). 
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Mycobacterial stimuli upregulated neuronal expression of MHC I, the antigen presenting 
molecule, suggesting that infected neurons may have an increased ability to stimulate T cells, 
particularly CD8+ T cells against mycobacterial antigens. MHC II was undetectable in 
infected and non-infected neuron cultures which is to be expected as reports show neurons do 
not express the surface protein (Figure 3-2 B).  
To continue analysis of neuronal immune related functions activated through cells interaction 
with Mtb, the expression of selected cytokines was measured. The cytokine panel chosen was 
guided by various reports in viral and bacterial CNS infections where induction of neuronal 
cytokines such as IL1β, TNF and IL10 was observed. The expression levels of these 
cytokines in infected neuronal cultures were determined by intracellular staining for flow 
cytometry analysis. Mycobacterial infection significantly upregulated the expression of IL1β 
in neurons (Figure 3-2 C). There was no significant difference in neuronal expression of TNF 
and IL10 in infected and non-infected cultures (Figure 3-3 D, E). In summary, mycobacterial 
infection of neuronal cultures induces neuron activation which includes upregulation of 
MHC I and inflammatory cytokines that are essential to the resolution of mycobacterial 
infections.  
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Figure 3-2:  Cell surface expression of neurons after infection with mycobacteria. Results 
represents flow cytometry analysis of the percentage of β-III-tubulin+ primary neurons 
expressing (A) MHC class I and (B) MHC class II measured in H37Rv infected cultures and 
non-infected controls. Data are mean ± SD. *P < 0.05, **P < 0.01. NI – non-infected 
   Figure 3-3 Cytokine expressions of primary neurons after infection with Mtb. Neurons were 
infected with H37Rv (MOI = 30:1) for 24 hours and analysed by flow cytometry for cytokine 
productions of (A) IL1β, (B) TNF and (C) IL10. The results represent percentages of β-III-
tubulin+ neurons expressing cytokines in infected cultures and non-infected controls. Data are 
mean ± SD. *P < 0.05, **P < 0.01. NI – non-infected 
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3.2. Neuronal response to mycobacterial infection in the presence of T cells  
As previously described, neuronal expression of MHC class I and inflammatory cytokines were 
upregulated under infectious conditions that suggests potential interaction of neurons with T cell 
may influence disease outcome. So a co-culture model was used to address the effect of T cells on 
neuronal inflammation or neuronal response to Mtb. Neuron T cell co-culture was established by 
isolating splenic T cells from mice via cell sorting using FACS. CD3+ T cells were sorted and co-
cultured with H37Rv infected neuron cultures (2.5). Flow cytometry was used for analysis of 
neuronal surface expression of MHC class I and II, as well as cytokines, IL1β, TNF and IL10, in 
neuron only cultures and neurons co-cultured with CD3+ T cells. The percentage of neurons 
expressing MHC class I was significantly decreased upon co-culture with T cells when comparing 
between infected neuron only cultures and neuron T cell co-cultures. No significant difference 
was observed in MHC class I expression in non-infected neuron with or without T cells (Figure 3-
4 A). Addition of T cells had on effect on levels of neuronal MHC class II expression (Figure 3-4 
B). Presence of T cells also resulted in reduction in IL1β expression in neurons (Figure 3-4 C). 
No significant changes were observed in TNF and IL10 expression levels (Figure 3-4 D, E). The 
secretion of cytokines in the supernatants were analysed by ELISA for the amounts of IL6 and 
IL10 in neuron only culture and neuron T cell co-cultures. To study the effects of cell-to-cell 
contact on neuronal response, the concentrations of cytokines from the direct co-culture system 
were compared to that of the transwell system. Production of IL6 was significantly increased in 
H37Rv infected neuron only culture at a mean concentration of 0.24 ng/ml as compared to 0.03 
ng/ml in non-infected cultures. However, no changes were observed in IL6 production in both 
direct and transwell co-cultures (Figure 3-5 A). Mycobacterial infection did not have any effect 
on the production of IL10 in neuron only cultures. There was a significant difference in IL10 
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production in direct neuron T cell co-culture which was not observed in transwell co-cultures 
(Figure 3-5 B).  
These data suggest that T cells are able to mediate MHC class I and IL1β expression in the Mtb 
infected neurons. The secretion of IL10 in neuron T cell co-culture is contact dependant during 
Mtb infection. 
  
Figure 3-4: Primary neurons were infected with H37Rv, MOI = 30:1 for 24 hours. Infected 
neurons cultures and non-infected controls were co-cultured with splenic CD3+ T cells at a ratio 
of 1:1 for 48 hours. FACS was used for analysis of neuronal surface expression of A) MHC class 
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I, B) MHC class II and intracellular expression of C) IL1β, D) TNF and E) IL10 in infected and 
non-infected neuron cultures. The graph indicates the percentage of β-III-tubulin+ neurons 
expressing the surface proteins MHC class I, MHC class II and inflammatory cytokines (IL1β, 
TNF and IL10) in neuron only culture and neurons co-cultured with T cells. N – neurons, T – T 
cells. Data are mean ± SD. *P < 0.05, **P < 0.01, ***P < 0.001 
   
Figure 3-5: The concentrations of IL6 and IL10 secreted in culture supernatants by infected 
and non-infected neurons with and without T cells analysed using ELISA. Neurons were 
infected with Mtb for 24 hours and incubated 48 hours with T cells, in either direct or 
indirect (transwell) co-cultures systems. NI–non-infected, N-neurons, T – T cells. Data are 
mean ± SD. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001 
3.3. Role of neurons in mediating T cell responses 
The role of neurons in regulation of T cell responses is well studied in CNS autoimmune and 
neurodegenerative disorders. Considering the critical role of T cells in resolution of 
infectious pathogens, the study sought to characterise the neuron mediated T cell responses in 
mycobacterial infection in vitro. The effects of neuron T cell interaction on T cell 
differentiation were determined using a co-culture model. Cells were collected after 48hours 
of co-culture and expressional levels of T cells specific transcription factors, Tbet, FoxP3, 
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Gata3 and RorγT, were analysed by flow cytometry. Analysis was performed on CD3+CD4+ 
and CD3+CD8+ T lymphocytes (Figure A-3). There was a significant increase in the 
percentage of CD4+ and CD8+ T cells expressing Tbet in the presence of neurons (Figure 3-6 
A). The upregulation of Tbet was observed in co-cultures of T cells with infected and non-
infected neurons suggesting that independent of infection, the direct interaction with neurons 
is sufficient to drive a Th1 response in CD4+ and CD8+ T cells. Similar results were observed 
in the expression of RorγT and Gata3 (Figure 3-6 A).  
The effects of cell to cell contact responses were evaluated against transwell system co-
cultures where neurons and T cells were separated by a membrane and a co-culture of T cells 
with neuron conditioned media. CD3+CD4+ and CD3+CD8+ T cells were analysed by flow 
cytometry for the T cell transcription factors. There was no significant difference in the 
percentage of CD4+ T cells expressing Tbet, RorγT, Gata3 and FoxP3 (Figure 3-6 B). 
However, there was difference in the CD8+ T cells expressing RorγT in cultures of T cells 
with infected and non-infected neuronal media. No changes were observed in the percentage 
of CD8+ T cells expressing Tbet and Gata3 (Figure 3-6 B). Through transwell separation, 
neurons were still able to upregulate expression of Tbet, RorγT, Gata3 and FoxP3 in CD4+ T 
cells (Figure 3-6 C). In ELISA analysis of supernatants, IFN-γ and IL10 production was 
undetectable in supernatants of T cells only cultures and increased in culture supernatants of 
neurons co-cultures directly with CD3+ T cells. There was difference in the production of 
both cytokines in infected and non-infected transwell system co-cultures (Figure 3-7). These 
data demonstrate direct contact between neurons and T cells plays a significant role in T cell 
transcription factors expression and probable T cell activation in vitro. 
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Figure 3-6: A) These data represents FACS analysis of the percentage of CD3+CD4+ and 
C3+CD8+ T cells expressing transcription factors in T cell only cultures (white bar) and T 
cells co-cultured with neurons (grey bar - non infected; black bar – H37Rv infected) at a ratio 
of 1:1 for 48 hours B) Transcription factors expression in sorted T cells after with neuron 
culture conditioned media. C) FACS analysis neuron T cell co-culture where direct contact 
was prevented using a transwell system and T cells only served a control. N – neurons, T – T 
cells. Data are mean ± SD. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001 
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Figure 3-7:  IFN-γ and IL10 production in culture supernatants of T cells and T cells co-
culture with neurons directly or through a transwell system assessed by ELISA. N – neurons, 
T – T cells. Data are mean ± SD. ND- non detectable. 
3.4. Effects of mycobacterial infection on neuronal phenotype and function in vivo 
Neurons internalize Mtb bacilli in vivo 7 days after infection (Randall et al., 2014) and 
whether they respond to the internalization and presence of mycobacteria in vivo remains 
unclear. To address this, adult C5BL/6 mice were infected intracerebrally with Mtb (H37Rv 
strain) (2.8). The activation status of neurons was analysed by flow cytometry for a selection 
of cell surface markers and expression of inflammatory cytokines. Neurons were defined as 
β-III-tubulin+ cells for FACS analysis and evaluated from whole brains collected at different 
time points post infection. A significant reduction in β-III-tubulin+ neurons percentage 
between non-infected and day 14 of infection was observed (Figure 3-8 A).  Analysis of 
neuronal MHC class I revealed a marked in vivo activation of β-III-tubulin+ neurons (Figure 
3-8 B) which gradually increased over the course of infection and peaked at day 14. 
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Cytokines (IL1 β, IL6, TNF an IL10) expression was also assessed due to their well-
documented key roles in response to mycobacterial infection. Flow cytometry analysis of 
these molecules, except IL10, showed their expression increased significantly following the 
same kinetics as MHC class I (Figure 3-8 C). Results indicate substantial activation of 
neurons demonstrated by an increase in MHC class I expression and inflammatory response 
in vivo during acute mycobacterial infection. 
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Figure 3-8: Neurons from whole brains of (NI, n=4) Mtb infected C57BL/6 mice at day 7 
(n=4) and day 14 (n=4) analysed by flow cytometry by gating on β-III-tubulin+ neuronal 
cells. A) Comparison in percentages of acquired neurons between 7 and 14 days of infection. 
B) Percentage of MHC class I expression by neurons. C) IL1β, IL6, TNF and IL10 
expression by neurons gated on β-III-tubulin+ cells and was analysed by flow cytometry. NI – 
non-infected, D7 – day 7, D14 – day 14. Data are mean ± SD. *P < 0.05, **P < 0.01, ***P < 
0.001. 
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3.5. Neuronal response to infection by less pathogenic mycobacteria (BCG-GFP) 
In the initial experiments (3.1.1) it was shown that neurons can internalize BCG. To assess 
neuronal response to BCG, cells were infected (MOI = 30:1) for 24 hours and stained with β-
III-tubulin antibody (neuronal marker) for flow cytometry analysis of selected of cell surface 
molecules and cytokines. Neuron T cell interactions were studied using a co-culture model of 
primary neurons and splenic T cells sorted by CD4+ and CD8+ using MACS beads sorting 
system. The two populations of T cells were co-cultured with BCG infected and non-infected 
neurons at a ratio of 1:1 for 48 hours. Flow cytometry was used to determine the percentage 
of neurons expressing MHC class I, IL1β, TNF and IL10 in neuron only cultures and co-
cultures of neurons with CD4+ or CD8+ T cells. For control, CD4+ or CD8+ T cells were 
cultured alone. To analyse direct cell-to-cell contact effects, a co-culture was also established 
using a transwell system (neurons and sorted CD4+ T cells separated by a membrane). BCG 
infection upregulated neuronal expressions of MHC I in neuron only cultures with no 
significant in co-culture samples (Figure 3-9 A). Infection and the T cells did not have any 
effect on MHC class II expression (Figure 3-9 B). IL1β was significantly increased in BCG-
GFP infected neuron cultures. No change was observed in the percentage of CD8+ T cell co-
culture but there was significant decrease in CD4+ T cells in direct and transwell co-cultures 
(Figure 3-9 C). Similar reduction of IL10 was also observed in the CD4+ T cells transwell co-
culture post BCG-GFP infection, but overall, there was no significant difference in the 
expression of TNF and IL10 amongst other groups (Figure 3-9 D, E).  
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Figure 3-9: Neuronal expression of MHC I, MHC II, IL1β, TNF and IL10 analysed by flow 
cytometry before and after co-culture with CD4+ and CD8+ T cells (sorted from spleens of 
wild type C57BL/6 adult mice) in the presence and absence of infection. Neurons were 
infected with BCG-GFP at MOI=30 for 24 hours then incubated with T cells at a ratio of 1:1 
for 48 hours. NI – non-infected, N – neuron. Data are mean ± SD. *P < 0.05, **P < 0.01, 
***P < 0.001. 
3.6. T cell responses to neuron T cell interaction 
To study neuronal role in mediating T cell response during BCG-GFP infection, cells in 
CD4+ and CD8+ co-cultures were stained with T cell transcription factors Tbet, RorγT, Gata3 
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and FoxP3. Flow cytometry was used to analyse the percentage of CD8+ and CD4+ T cells 
expressing selected transcription factors. There was a significant difference in the percentage 
of CD8+ and CD4+ T cells expressing Tbet in T cell only and non-infected co-cultures 
(Figure 3-10 A). Increase in Gata3 expression was observed between CD8+ only T cell and 
non-infected neurons co-cultures with CD8+ T cells and a decrease in comparison between 
infected and non-infected co-culture (Figure 3-10 C). There was no difference in the 
expression of RorγT (Figure 3-9 B) and FoxP3 (Figure 3-9 D). Therefore, BCG-GFP 
infection and the presence of neurons mediate the expression of Tbet and Gata3 in T cells. 
 37 
 
 Figure 3-10: T cell expression of transcription factors detected by flow cytometry in T cells 
and T cells co-cultured with neurons. NI – non-infected, N – neuron. Data are mean ± SD. *P 
< 0.05, **P < 0.01, ***P < 0.001. 
3.7. Neuronal response to BCG-GFP infection in vivo 
To investigate the neuronal responses to BCG infection in vivo, adult C57BL/6 mice were 
infected with BCG-GFP by intracerebral infection and whole brains were collected at 3 and 6 
weeks of infection. Single cell suspension was performed and 1x106 cells were stained for 
analysis of the effect of intracerebral BCG infection on neuronal phenotype and function in 
vivo. Neurons percentages were constant throughout infection. BCG infection at week 6 
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induced production of neuronal MHC class I but did not appear to have any significant effect 
on their capacity to produce cytokines (Figure 3-11) 
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Figure 3-11: FACS analysis of neurons stained from whole brains of adult mice infected 
with BCG-GFP for 3-6 weeks. Results represent percentage of expression by β-III-tubulin+ 
neurons. 1x106 cells were stained with respective antibodies prior to FACS analysis. NI – 
non-infected, Wk – week. Data are mean ± SD. *P < 0.05, **P < 0.01, ***P < 0.001, ****P 
<0.0001. 
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4. DISCUSSION 
Numerous bacterial pathogens, such as Mycobacterium tuberculosis (Mtb) and Listeria 
monocytogenes, are able to invade the CNS to establish infection (Drevets et al., 2004). 
Several studies have reported on different types of CNS resident cells, such as neurons, 
microglia and astrocytes, targeted by Mtb for invasion. Due to the phagocytic nature of 
microglia, most of these studies focus on the relationship of Mtb bacilli with microglia 
(Shastri et al., 2013, Rock et al., 2005, Peterson et al., 1995). However, recent observations 
have shown that Mtb bacilli can be internalized by neurons and elicited neuronal responses 
(Randall et al., 2014, Francisco et al., 2015b). The data from this study are consistent with 
the previous findings and confirm the internalization of Mtb bacilli by neurons. Furthermore, 
neurons can also internalize BCG, a less pathogenic strain of Mtb. Interaction of neurons 
with live Mtb or BCG results in direct cell activation as reflected by changes in neuronal 
phenotype and cytokine expression in vitro and in vivo. Data also shows neurons are readily 
activated by BCG infection in vitro with minimal to no changes in vivo. Mycobacterium 
tuberculosis and BCG infection of neurons increased their expression of MHC class I but not 
MHC class II molecules, suggesting that infected neurons may have an increased ability to 
stimulate T cells (specifically CD8+ T cells) against mycobacterial antigens as CD8 TCRs 
recognize antigenic peptides associated with MHC class I molecules. It has been long 
established that the interaction between CD4+ T cells and macrophages are critical for 
immune protection against tuberculosis, particularly in bacterial clearance and containment 
(Orme et al., 1993, Ndlovu and Marakalala, 2016, Boom et al., 2003).  Clinical importance of 
CD4+ T cells have been demonstrated in HIV patients with increased risk for both 
tuberculosis infection and reactivation. Although initially CD8+ T cells were believed to be 
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less important, increasing evidence has shown their essential role in this immune response to 
Mtb infection. In the absence of MHC class I presentation to CD8+ T cells, the mice were 
susceptible to Mtb and BCG infection (Flynn et al., 1992, Ladel et al., 1995), Populations of 
CD8+ T cells form part of T cells subsets mediating protection against respiratory 
mycobacterium challenge (Orme, 1987, Boom et al., 2003).  
Mycobacterial infection of neurons induces the upregulation of inflammatory cytokines such 
as IL1β, IL6 and a non-significant expression TNF and regulatory cytokine IL10. Based on 
the percentage of neurons expressing of selected surface molecules and cytokines, Mtb 
infected neurons are more efficient than BCG infected neurons at eliciting specific cellular 
responses in vitro. This may be attributed to neuronal efficiency at internalizing virulent Mtb 
than avirulent BCG. A study demonstrated that human microglia internalize Mtb bacilli more 
than avirulent Mycobacterium avium resulting in lasting inhibition of IL1 and IL10 
productions (Curto et al., 2004). However, this present study was not designed to show a 
clear association between strains of Mtb and frequency of neuronal responses. High 
expression of cytokines such as TNF-α have previously been shown to be related to extensive 
mycobacterial damage seen in animals infected with H37Rv strain (Nagesh Babu et al., 
2008). The levels of cytokines produced may have a significant impact on neuronal disease 
and protective immunity against Mtb infections. Many studies have focused on pro- and anti-
inflammatory cytokines responses to infection with pro-inflammatory cytokines considered 
traditionally harmful in the CNS. Initial inflammatory responses to pathogen neuronal 
invasion are not always bad as they provide signs that identify the CNS as a site of infection 
and results in the recruitment of leukocytes into infected CNS to promote pathogen 
containment and clearance. This is not to disregard the role of inflammatory responses in 
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worsening infection, resulting neuronal sequelae (Grimwood et al., 2000, Dawson et al., 
1999). Therefore, immune response must maintain a careful balance between preventing 
apoptosis (due to non-regenerative nature of neurons) and containing infection. And 
regardless of the outcome to ensue following increased neuronal expression of inflammatory 
molecules, these data show neurons also play a role in immune reaction during Mtb and BCG 
challenge.  
Animal models of cerebral tuberculosis have been established in mice (van Well et al., 2007, 
Zucchi et al., 2012, Wu et al., 2000). The experimental model was used in this study to 
reproduce more closely the human disease as in vitro system cannot mimic complex 
interactions of several cell types and compartments in vivo. Interestingly, the expression 
patterns of neuronal surface molecules (MHC class I) and cytokines (IL1β, IL6, TNF and 
IL10) at day 14 post intracerebral mycobacterial infection, corroborated with in vitro data. 
There was little to no neuronal response to BCG infection in vivo except for neuronal 
expression of MHC class I. This may be in line with cellular responses dependent on 
excessive inflammation associated with virulent pathogens. The levels of cytokines 
expression in vitro were low which may render them non-detectable in analysis of the whole 
brain where responses are affected the presence of other cell types. 
The role of the immune system is to defend the body against infection and injury. CNS is no 
longer seen as an immune privileged site (Louveau et al., 2015). In CNS inflammatory 
conditions, T cells infiltrate the parenchyma and upon severe immune attack, damage takes 
place. T cells also play a role in tissue homeostasis and exert neuroprotective effects in 
neuronal injury (Walsh et al., 2015, Steinman, 2015, Gadani et al., 2015), autoimmunity 
(Kipnis et al., 2001, Kipnis et al., 2002) and neurodegenerative disorders (Stangel, 2012, 
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Maghzi et al., 2013).  Therefore, this study sought to investigate functional responses of 
infected primary neurons after encounter with CD3+ T cells. The consequences of such an 
encounter are important as they dictate the outcome of the disease. Current study 
demonstrated that neuronal contact with T cells leads to significant decrease in neuronal 
expression of MHC class I, IL1β and TNF by FACS analysis.  And, ELISA analysis of 
supernatants has shown a decreased production of IL6 in neuron T cell co-cultures in 
comparison with the neuron only cultures. These data suggest possible cell death of infected 
neurons expressing MHC class I due to interaction with cytotoxic CD8+ T cells. Neurons 
have been shown to express MHC class I in inflammatory setting (Foster et al., 2002, 
Chevalier et al., 2011, Neumann et al., 1997) and during neuronal development (Shatz, 2009, 
Corriveau et al., 1998, Chacon and Boulanger, 2013). Neuronal MCH class I expression in 
those settings was capable inducing CD8+ T cells proliferation and triggering Fas (Fas on 
neurons and Fas ligand on CD8+ T cells) (Meuth et al., 2009, Medana et al., 2000, Neumann 
et al., 1997) and perforin based cytotoxic neuronal killing (Cebrian et al., 2014). Another 
plausible scenario is neurons or Mtb/ BCG downregulates MHC class I to evade possible 
interaction with CD8+ T cells. Reduction of cytokines such as IL1β, IL6 and TNF mediated 
by the presence of T cells may also be attributed to apoptosis of inflamed neurons induced by 
interaction with cytotoxic CD8+ T cells. CD4+ T cells cannot recognize antigens on neurons 
due to lack of MHC class II molecules but they have been shown to utilise alternative 
pathways to interact with neurons (Liu et al., 2006). IL10 production in supernatants of 
neuron T cell co-cultures indicates initiation of neuroprotective responses with the induction 
of Th2 regulatory T cells. IL10 expressed by brain Tregs have been shown to suppress the 
inflammatory responses of active microglia (Xie et al., 2015). These results indicate distinct 
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roles of CD8+ and CD4+ T cell subsets, supporting the concept of T cells have 
neuroprotective and/ or neurodegenerative roles. This is shown in previous co-culture 
experiments in which activated human CD8+ T cells inhibit neurite outgrowth in a contact 
dependent manner whereas activated CD4+ T cells promote neurite outgrowth (Pool et al., 
2012, Walsh et al., 2015). In experimental models of CNS injury, T cells protect neurons and 
increase neuronal survival (Kipnis et al., 2002, Kipnis et al., 2001). Therefore, the 
understanding of neuroprotective and neurodegenerative contributions of T cells in 
mycobacterial infection of CNS warrants future studies. 
Studies on immune functions of neurons have indicated that neurons participate in immune 
regulation of by controlling infiltrated T cells. It is well established that APCs are specialized 
for naïve T cell activation and normally APCs interact with T cells by priming and activating 
them. Molecules released in response to a pathological stimulus also influence the type of T 
cell responses. Neurons have been shown to have a direct immune regulatory role on T cells 
and CNS inflammation (Liu et al., 2006). Neurons have been shown to use direct and indirect 
communication with T cells to regulate T cell response. Present study investigated the 
immune regulatory roles of neurons under Mtb/ BCG inflammatory. Given the data obtained 
from the neuron T cell co-cultures of this study, it is very likely that neurons exposed to 
mycobacteria are able to successfully stimulate T cell responses and this is supported by 
increased expression of T cell transcription factors. Mtb infected neurons play a direct role in 
immune regulation during neuron T cell interaction via cell-to-cell contact and/ or via 
specific cytokine expression. Neurons were able to induce T cell transcription factors such as 
expression of Tbet for Th1, RorγT for Th17 and Gata3 for Th2 responses. Reponses seem to 
be dependent on direct contact with neurons in contrast to conditioned media and transwell 
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cultures which had no significant changes in both CD4+ and CD8+ populations and to a 
certain extent, independent of infection. ELISA analysis of co-culture supernatants showed 
an increased production of IFN-γ. It is plausible to suggest that recognition of specific MHC 
I peptide complexes by T cells promotes the release of IFN-γ which in turn enhances 
neuronal Fas expression and susceptibility to apoptosis. Enhanced Th1 cellular responses and 
increased production of IFN-γ are in line with reports in pulmonary TB where IFN-γ 
producing T cells are required for protective immunity and their arrival at the site of infection 
correlates with decreased bacterial growth (Green et al., 2013). Gata3 expression seen in 
CD4+ population is also confirmed by IL10 production significantly increased in co-culture 
supernatants. It was confirmed in this study neurons do not express MHC class II, therefore 
CD4+ T cells interaction with neurons will most likely be independent of MHCII/ TCR 
signalling T cell where responses do not necessarily require antigen recognition but rather 
induced by damage associated molecules expressed by neurons in response microbial 
antigens. These data confirm that neurons are capable of inducing T cell responses against 
mycobacteria.  
Proposed future studies will include elucidating mechanism of bacilli uptake where scanning 
and transmission electron microscope could be utilised to visualise interaction of bacilli with 
cultured neurons. Though intracerebral Mtb infection has been widely used as a reproducible 
in vivo model of CNS TB (Hsu et al., 2017, Francisco et al., 2015a), it is still not the natural 
way CNS TB is acquired in humans. In the animal models, mice do not show clinical signs of 
the disease which are necessary for clinical diagnosis. Nonetheless, the model can provide 
localized Mtb infection and the subsequent immune responses in the brain, which is useful 
for further investigate neuron T cell interaction in vivo, the phenotype and effect of CNS 
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infiltrated T cells – as well as analyse variety of cytokines and receptors elucidating 
signalling pathways that orchestrate immunological responses to CNS TB. More experiments 
should have also been done to confirm progression of disease as CNS TB develops not 
directly by presence of bacilli in the meninges but by release of bacilli from focal lesions. 
Histological analysis of the whole brain would have highlighted the outcome of infection.  
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5. CONCLUSION 
Traditionally, neurons are believed to be passive in the immune responses of the CNS. 
Considering the novel observations that neurons directly interact with Mycobacterium 
tuberculosis, neurons are capable of inducing immune responses and actively involved in CNS 
immunity. Recent findings have shown the immune regulatory role of neurons in many CNS 
disorders where they utilised varying mechanisms to influence T cell responses. This study 
suggests that neuronal responses to Mtb may preferentially drive T helper cells to mature into 
Th1 and/or Th2 cell types therefore controlling the generation of type 1 or type 2 immune 
responses to Mtb - allowing inflammatory response to clear pathogens as well as limit damage to 
the CNS. On the contrary, BCG infection affects neuronal phenotype and upregulates cytokine 
production but does not appear to participate actively in the activation and maturation of T cells. 
Applying immunological methodologies to neurological studies highlights interesting 
interactions between the immune and nervous system and shows that immune mechanisms are 
important in a wide range of neurological disorders. If neurons can induce an appropriate 
immune response to mycobacteria, then targeting mycobacterial antigens to neurons may form 
the basis of new generation of therapeutics against CNS-TB with improved outcomes in terms of 
immune protection and neurological morbidity. And add new understanding of the immune 
regulatory process during tuberculosis infection of the CNS with emphasis on the respective 
roles of neurons and immune cells. 
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APPENDIX A  
  
1.1. Table A-1: FACS T Cell Antibody Panel 
Antibody Fluorophore Dilution  Clone No. Company 
CD3 BV421 1:100 145-2C11 eBioscience 
CD4 Alexa 700 1:100 RM4-5 BD Pharmingen 
CD8 APC-CY7 1:100 53-6.7 BD Pharmingen 
CD44 FITC 1:100 Pgp-1Ly-24 BD Pharmingen 
T cell transcription factors 
Tbet PE 1:50 O4-46 BD Pharmingen 
RorYT PERCP 1:50 Q31-378 BD Pharmingen 
Gata3 PE-CY7 1:50 L50-823 BD Pharmingen 
FoxP3 Alexa 647 1:50 MF23 BD Pharmingen 
 
1.2. Table A-2: FACS Neuron Antibody Panel 
Ab Fluorophore Dilution  Clone No. Company 
βTubulin Alexa 647 1:50 EP1569Y Abcam 
MHC I PE 1:100 AF6-88.55.3 eBioscience 
MHC II Alexa 700 1:50 M5/114.15.2 eBioscience 
TNF APC-CY7 1:50 MP6-XT22 BD Pharmingen 
IL1β PE-CY7 1:50 NJTEN3 eBioscience 
IL10 BV711 1:50 JES5-16E3 BD Horizon 
 
1.3. Table A-3: ELISA Antibodies and Standards 
Antibody [Coating] Company  
IL1β 4µg/ml R&D Systems 
IL4  R&D Systems 
IL6 2µg/ml R&D Systems 
IL10 2µg/ml R&D Systems 
TNFα 4µg/ml R&D Systems 
Antibody [Detection] Enzyme & Dilution Company 
IL1β 400ng/ml Strep AKP 1:1000 R&D Systems 
IL4   R&D Systems 
IL6 400ng/ml Strep AKP 1:1000 R&D Systems 
IL10 200ng/ml Strep AKP 1:1000 R&D Systems 
TNFα 200ng/ml Strep AKP 1:1000 R&D Systems 
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Sample [Recombinant] Company 
IL1β 2ng/ml R&D Systems 
IL4  R&D Systems 
IL6 1ng/ml R&D Systems 
IL10 4ng/ml R&D Systems 
TNFα 1ng/ml R&D Systems 
 
Figure A-1: Gating strategy for splenic CD3+ T cells sort 
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Figure A-2: Gating strategy for in vitro βtubulin+ neurons 
 
  
Figure A-3: Gating strategy for in vitro CD3+CD4+ and CD3+CD4+ T cells   
 
 
 
 
Primary neurons  Singlets Control β-III-tubulin+ 
Lymphocytes    Singlets Control CD3+CD8+
Control   CD3+CD4+
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Figure A-4: In vivo βtubulin+ neuron gating 
 
 
 
 
  
Neurons      Singlets  
Control     β-III-tubulin+
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